Recent Updates
Recently added Catalysts
NKTX Positive Sentiment Score: 70/100

Nkarta to Participate in an Upcoming Investor Conference

Tuesday, November 12, 2024 1 min read
Key Takeaway: Nkarta, Inc. has announced its participation in the Stifel 2024 Healthcare Conference, showcasing its advancements in engineered natural killer cell therapies. The event will feature a fireside chat at 10:55 a.m. ET and will be accessible via a live webcast. Nkarta is known for its innovative approaches to developing off-the-shelf NK cell therapies, integrating advanced technologies to enhance treatment options. The replay will be available on Nkarta’s website for approximately 90 days following the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Nkarta is advancing engineered NK cell therapies which are innovative.
  • Participation in a prominent investor conference may attract attention.
  • The webcast allows broader access to potential investors and stakeholders.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:
Stifel 2024 Healthcare Conference
10:55 a.m. ET – fireside chat
A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact:

Frequently Asked Questions

What conference is Nkarta participating in?

Nkarta is participating in the Stifel 2024 Healthcare Conference.

When is Nkarta's fireside chat scheduled?

The fireside chat is scheduled for 10:55 a.m. ET.

Where can I watch Nkarta's conference webcast?

The webcast is available on Nkarta’s Investors section of their website.

How long will the conference replay be available?

The replay will be archived for approximately 90 days.

What does Nkarta specialize in?

Nkarta specializes in engineered natural killer (NK) cell therapies.

Tags: NKTX Viatris Investor Conferences Healthcare Nkarta NK cell therapies Stifel 2024 biopharmaceutical investor conference
Last updated: Nov 12, 2024